Thyroid hormone replacement therapy in the perinatal period: neurologic considerations.
D000818:Animals; D000831:Animals, Newborn; D002531:Cerebellum / Q000378:metabolism; D003409:Congenital Hypothyroidism; D004247:DNA / Q000378:metabolism; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced / Q000150:complications; D007037:Hypothyroidism / Q000188:drug therapy; D007231:Infant, Newborn; D011247:Pregnancy; D051381:Rats; D013963:Thyroid Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D013974:Thyroxine / Q000009:adverse effects / Q000627:therapeutic use; D014284:Triiodothyronine / Q000009:adverse effects / Q000627:therapeutic use
D013963:Thyroid Hormones; D014284:Triiodothyronine; D004247:DNA; D013974:Thyroxine